Prostatic Neoplasms Completed Phase 2 Trials for Enzalutamide (DB08899)

Also known as: Neoplasm,Prostatic / Neoplasms, Prostatic / Prostatic Neoplasm

IndicationStatusPhase
DBCOND0028225 (Prostatic Neoplasms)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02034552A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)Treatment
NCT01288911A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate CancerTreatment